Breakdown | ||||
Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.10B | 1.09B | 1.09B | 1.11B | 1.16B | Gross Profit |
72.80M | 72.50M | 72.70M | 73.40M | 72.90M | EBIT |
39.90M | 38.30M | 32.40M | 35.80M | 35.50M | EBITDA |
49.10M | 47.30M | 44.90M | 50.00M | 32.70M | Net Income Common Stockholders |
25.50M | 25.10M | 23.40M | 26.30M | 12.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
7.00M | 37.30M | 35.30M | 19.30M | 50.60M | Total Assets |
179.60M | 195.30M | 189.40M | 186.20M | 232.40M | Total Debt |
48.50M | 63.40M | 74.70M | 100.50M | 163.50M | Net Debt |
41.50M | 26.10M | 39.40M | 81.20M | 112.90M | Total Liabilities |
182.90M | 211.60M | 221.40M | 243.90M | 314.00M | Stockholders Equity |
-3.30M | -16.30M | -32.00M | -57.70M | -81.60M |
Cash Flow | Free Cash Flow | |||
14.70M | 33.00M | 47.80M | 39.00M | 14.10M | Operating Cash Flow |
18.10M | 36.40M | 49.80M | 41.40M | 23.40M | Investing Cash Flow |
-4.40M | -3.50M | 12.30M | 4.40M | -4.70M | Financing Cash Flow |
-44.00M | -30.90M | -46.10M | -76.90M | 24.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | £11.63B | 14.92 | 65.29% | 2.18% | 12.83% | 15.54% | |
73 Outperform | £25.46B | 22.60 | 10.18% | 3.29% | ― | ― | |
70 Outperform | £7.44B | 14.58 | 17.19% | 0.81% | 6.87% | 22.36% | |
64 Neutral | £5.88B | 43.01 | 2.25% | 5.14% | 2.66% | 80.49% | |
59 Neutral | $30.54B | 0.25 | -13.23% | 4.04% | 2.36% | -49.53% | |
56 Neutral | £136.06M | 5.35 | 9.07% | ― | ― |